843 related articles for article (PubMed ID: 6321555)
1. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
[TBL] [Abstract][Full Text] [Related]
2. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
[TBL] [Abstract][Full Text] [Related]
3. The effect of portacaval shunt on hepatic lipoprotein metabolism in familial hypercholesterolemia.
Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Porter KA; Brewer HB
J Surg Res; 1985 Nov; 39(5):369-77. PubMed ID: 4057999
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects.
Hoeg JM; Edge SB; Demosky SJ; Starzl TE; Triche T; Gregg RE; Brewer HB
Biochim Biophys Acta; 1986 May; 876(3):646-57. PubMed ID: 3707989
[TBL] [Abstract][Full Text] [Related]
5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
6. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
8. Decreased very low density lipoprotein fluidity in familial hypercholesterolemia.
Klein L; Aviram M; Brook GJ; Mokady S; Cogan U
Isr J Med Sci; 1991 Feb; 27(2):70-4. PubMed ID: 2004886
[TBL] [Abstract][Full Text] [Related]
9. Genetics of the low density lipoprotein receptor: I. Low density lipoprotein receptor activity in cultured fibroblasts from subjects with or without familial hypercholesterolemia.
Maartmann-Moe K; Berg-Johnsen P
Clin Genet; 1981 Aug; 20(2):90-103. PubMed ID: 6273032
[TBL] [Abstract][Full Text] [Related]
10. [Effect of cyclic AMP on the metabolism of low density lipoproteins and cholesterol in fibroblasts of normal subjects and subjects with homozygous type familial IIa hypercholesterolemia].
Polonovski J; Maziere JC; Maziere C; Gardette J; Mora L; Barbu V
Bull Acad Natl Med; 1983; 167(7):737-44. PubMed ID: 6320989
[No Abstract] [Full Text] [Related]
11. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein metabolism in familial hypercholesterolemia.
Shepherd J; Packard CJ
Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages.
Angelin B
Biochem J; 1988 Oct; 255(2):529-34. PubMed ID: 3202831
[TBL] [Abstract][Full Text] [Related]
14. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
15. [Catabolism of low-density lipoproteins via receptors and its regulation].
Mazière JC; Mazière C; Gardette J; Polonovski J
Ann Biol Clin (Paris); 1986; 44(5):545-50. PubMed ID: 3544977
[TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolemia: dissection of a receptor disease.
Schneider WJ
Z Kardiol; 1990; 79 Suppl 3():3-7. PubMed ID: 2099041
[TBL] [Abstract][Full Text] [Related]
17. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
[TBL] [Abstract][Full Text] [Related]
18. Homozygous familial hypercholesterolemia. A possible biochemical explanation of clinical heterogeneity.
Breslow JL; Spaulding DR; Lux SE; Levy RI; Lees RS
N Engl J Med; 1975 Oct; 293(18):900-3. PubMed ID: 170518
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
Bilheimer DW; East C; Grundy SM; Nora JJ
Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lipase activity and high density lipoproteins in familial hypercholesterolemia: adaptational mechanisms for LDL-receptor deficient state.
Moriguchi EH; Tamachi H; Goto Y
Tokai J Exp Clin Med; 1990 Nov; 15(6):401-6. PubMed ID: 1966695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
